Back to Annual Meeting

Back to Annual Meeting

Abstract #147994

• Audio (mp3) recording
• Slides (pdf) or Handout
• Multimedia recording

Edward Morse, PhD¹, Patricia M. Morse, PhD², Samuel Burgess, MA, MPH³, and Stan Hoogerwerf, MA². (1) Pediatrics, Tulane University, 1430 Tulane Ave SL-37, New Orleans, LA 70112, 828.260.2873, gbear@tulane.edu, (2) Psychiatry, LSU Health Sciences Center, 1542 Tulane Ave, New Orleans, LA 70112, (3) Louisiana Office of Public Health, 10 10 Common St, New Orleans, LA 70112

Objective: To examine the differential effects of self-efficacy and self-esteem on stimulating readiness to change HIV/HCV sexual and drug use risk behaviors in a cohort of young African American IDUs participating in a longitudinal study comparing the relative efficacy of 3 HIV/HCV risk reduction interventions. Methods: As part of a NIDA-funded risk reduction intervention study 211 incarcerated young African American IDUs were randomized to one of three intervention arms (counseling and testing (CT), pharmacy syringe purchase (PSP), and a client centered behavioral intervention (CCBI)). HIV, HCV, and Chlamydia laboratory data as well as baseline interview data measuring readiness to change, self-esteem, self-efficacy, and sexual and drug use risk behaviors were compared to parallel data gathered 6 months post incarceration. Results: At 6 month follow-up, syringe sharing was significantly reduced across all interventions by at least 25%. Increased self-efficacy and self-esteem resulted in increased readiness to change (r=.72; p<.01; r=.68; p<.01 respectively) which was significantly positively associated with HIV/HCV risk reduction (r=.71; p<.01). Conclusions: HIV/HCV risk reduction interventions that include increasing self-efficacy and self-esteem are likely to result in significant HIV/HCV risk behavior change and should be included in intervention and prevention efforts

Learning Objectives:

• Examine importance of self-esteem and self-efficacy in the development of HIV/HCV interventions.
• Develop a risk reduction plan for IDUs

Keywords: Intravenous Drug Use, HIV/AIDS

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

• Audio (mp3) recording
• Slides (pdf) or Handout
• Multimedia recording